Cargando…
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia
Cachexia is a wasting syndrome characterized by devastating skeletal muscle atrophy that dramatically increases mortality in various diseases, most notably in cancer patients with a penetrance of up to 80%. Knowledge regarding the mechanism of cancer‐induced cachexia remains very scarce, making cach...
Autores principales: | Wyart, Elisabeth, Hsu, Myriam Y, Sartori, Roberta, Mina, Erica, Rausch, Valentina, Pierobon, Elisa S, Mezzanotte, Mariarosa, Pezzini, Camilla, Bindels, Laure B, Lauria, Andrea, Penna, Fabio, Hirsch, Emilio, Martini, Miriam, Mazzone, Massimiliano, Roetto, Antonella, Geninatti Crich, Simonetta, Prenen, Hans, Sandri, Marco, Menga, Alessio, Porporato, Paolo E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982578/ https://www.ncbi.nlm.nih.gov/pubmed/35199910 http://dx.doi.org/10.15252/embr.202153746 |
Ejemplares similares
-
Cachexia, a Systemic Disease beyond Muscle Atrophy
por: Wyart, Elisabeth, et al.
Publicado: (2020) -
The Functional Versatility of Transferrin Receptor 2 and Its Therapeutic Value
por: Roetto, Antonella, et al.
Publicado: (2018) -
Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia
por: Rausch, Valentina, et al.
Publicado: (2021) -
Iron Overload, Oxidative Stress, and Ferroptosis in the Failing Heart and Liver
por: Mancardi, Daniele, et al.
Publicado: (2021) -
Activation of the Hepcidin-Ferroportin1 pathway in the brain and astrocytic–neuronal crosstalk to counteract iron dyshomeostasis during aging
por: Mezzanotte, Mariarosa, et al.
Publicado: (2022)